Drospirenone and Estetrol is indicated for:
Population group: women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
The decision to prescribe drospirenone/estetrol should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with drospirenone/estetrol compares with other combined hormonal contraceptives (CHCs).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Drospirenone and Estetrol is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.